View More
Gain expert insight into the emerging role of NRG1 fusions as rare oncogenic drivers in a variety of solid tumors and learn about the targeted therapies in development from expert commentaries, a text-based module, and a downloadable slideset.
Review this slideset on applying emerging research to biomarker testing and treatment strategies for patients with NRG1 fusion–driven cancers by Stephen V. Liu, MD, and Ryma Benayed, PhD.
Ryma Benayed, PhD
Stephen Liu, MD
Released: February 2, 2022
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.